299 related articles for article (PubMed ID: 17206675)
1. Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease.
te Velde AA; de Kort F; Sterrenburg E; Pronk I; ten Kate FJ; Hommes DW; van Deventer SJ
Inflamm Bowel Dis; 2007 Mar; 13(3):325-30. PubMed ID: 17206675
[TBL] [Abstract][Full Text] [Related]
2. High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis.
Holgersen K; Kutlu B; Fox B; Serikawa K; Lord J; Hansen AK; Holm TL
J Crohns Colitis; 2015 Jun; 9(6):492-506. PubMed ID: 25795566
[TBL] [Abstract][Full Text] [Related]
3. Comparison of experimental mouse models of inflammatory bowel disease.
Oh SY; Cho KA; Kang JL; Kim KH; Woo SY
Int J Mol Med; 2014 Feb; 33(2):333-40. PubMed ID: 24285285
[TBL] [Abstract][Full Text] [Related]
4. Glutathione peroxidase 2 and aquaporin 8 as new markers for colonic inflammation in experimental colitis and inflammatory bowel diseases: an important role for H2O2?
Te Velde AA; Pronk I; de Kort F; Stokkers PC
Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):555-60. PubMed ID: 18467915
[TBL] [Abstract][Full Text] [Related]
5. Divergent influence of microRNA-21 deletion on murine colitis phenotypes.
Wu F; Dong F; Arendovich N; Zhang J; Huang Y; Kwon JH
Inflamm Bowel Dis; 2014 Nov; 20(11):1972-85. PubMed ID: 25222661
[TBL] [Abstract][Full Text] [Related]
6. Methods of Inducing Inflammatory Bowel Disease in Mice.
Bang B; Lichtenberger LM
Curr Protoc Pharmacol; 2016 Mar; 72():5.58.1-5.58.42. PubMed ID: 26995548
[TBL] [Abstract][Full Text] [Related]
7. Exploration of Inflammatory Bowel Disease in Mice: Chemically Induced Murine Models of Inflammatory Bowel Disease (IBD).
Gadaleta RM; Garcia-Irigoyen O; Moschetta A
Curr Protoc Mouse Biol; 2017 Mar; 7(1):13-28. PubMed ID: 28252200
[TBL] [Abstract][Full Text] [Related]
8. PGRN protects against colitis progression in mice in an IL-10 and TNFR2 dependent manner.
Wei F; Zhang Y; Jian J; Mundra JJ; Tian Q; Lin J; Lafaille JJ; Tang W; Zhao W; Yu X; Liu CJ
Sci Rep; 2014 Nov; 4():7023. PubMed ID: 25387791
[TBL] [Abstract][Full Text] [Related]
9. Methods of inducing inflammatory bowel disease in mice.
Maxwell JR; Brown WA; Smith CL; Byrne FR; Viney JL
Curr Protoc Pharmacol; 2009 Dec; Chapter 5():Unit5.58. PubMed ID: 22294404
[TBL] [Abstract][Full Text] [Related]
10. Effect of recombinant Trichinella spiralis cysteine proteinase inhibitor on TNBS-induced experimental inflammatory bowel disease in mice.
Xu J; Liu M; Yu P; Wu L; Lu Y
Int Immunopharmacol; 2019 Jan; 66():28-40. PubMed ID: 30419451
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two models of inflammatory bowel disease in rats.
Catana CS; Magdas C; Tabaran FA; Crăciun EC; Deak G; Magdaş VA; Cozma V; Gherman CM; Berindan-Neagoe I; Dumitraşcu DL
Adv Clin Exp Med; 2018 May; 27(5):599-607. PubMed ID: 29616750
[TBL] [Abstract][Full Text] [Related]
12. Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel disease.
Zeng JQ; Xu CD; Zhou T; Wu J; Lin K; Liu W; Wang XQ
World J Gastroenterol; 2015 Jan; 21(1):187-95. PubMed ID: 25574091
[TBL] [Abstract][Full Text] [Related]
13. Prevention of colitis by interleukin 10-transduced T lymphocytes in the SCID mice transfer model.
Van Montfrans C; Rodriguez Pena MS; Pronk I; Ten Kate FJ; Te Velde AA; Van Deventer SJ
Gastroenterology; 2002 Dec; 123(6):1865-76. PubMed ID: 12454844
[TBL] [Abstract][Full Text] [Related]
14. CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in mice.
Maharshak N; Hart G; Ron E; Zelman E; Sagiv A; Arber N; Brazowski E; Margalit R; Elinav E; Shachar I
Inflamm Bowel Dis; 2010 Sep; 16(9):1496-504. PubMed ID: 20222120
[TBL] [Abstract][Full Text] [Related]
15. ETS-1 facilitates Th1 cell-mediated mucosal inflammation in inflammatory bowel diseases through upregulating CIRBP.
He Q; Gao H; Chang YL; Wu X; Lin R; Li G; Lin J; Lu H; Chen H; Li Z; Cong Y; Yao J; Liu Z
J Autoimmun; 2022 Oct; 132():102872. PubMed ID: 35926374
[TBL] [Abstract][Full Text] [Related]
16. Chronic Model of Inflammatory Bowel Disease in IL-10
Wang H; Vilches-Moure JG; Cherkaoui S; Tardy I; Alleaume C; Bettinger T; Lutz A; Paulmurugan R
Theranostics; 2019; 9(21):6031-6046. PubMed ID: 31534535
[No Abstract] [Full Text] [Related]
17. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
Lv QK; Liu JX; Li SN; Gao YJ; Lv Y; Xu ZP; Huang BX; Xu SY; Yang DX; Zeng YL; Liu DF; Wang W
Int J Mol Sci; 2015 Nov; 16(11):26654-66. PubMed ID: 26561804
[TBL] [Abstract][Full Text] [Related]
18. Aggravation of intestinal inflammation by depletion/deficiency of gammadelta T cells in different types of IBD animal models.
Kühl AA; Pawlowski NN; Grollich K; Loddenkemper C; Zeitz M; Hoffmann JC
J Leukoc Biol; 2007 Jan; 81(1):168-75. PubMed ID: 17041003
[TBL] [Abstract][Full Text] [Related]
19. Pro-inflammatory miR-223 mediates the cross-talk between the IL23 pathway and the intestinal barrier in inflammatory bowel disease.
Wang H; Chao K; Ng SC; Bai AH; Yu Q; Yu J; Li M; Cui Y; Chen M; Hu JF; Zhang S
Genome Biol; 2016 Mar; 17():58. PubMed ID: 27029486
[TBL] [Abstract][Full Text] [Related]
20. Effect of Trichinella spiralis intervention on TNBS-induced experimental colitis in mice.
Xu J; Yu P; Wu L; Liu M; Lu Y
Immunobiology; 2019 Jan; 224(1):147-153. PubMed ID: 30413272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
